IBDEI0SZ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13040,0)
 ;;=H40.053^^51^627^36
 ;;^UTILITY(U,$J,358.3,13040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13040,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,13040,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,13040,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,13041,0)
 ;;=H26.492^^51^627^37
 ;;^UTILITY(U,$J,358.3,13041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13041,1,3,0)
 ;;=3^PCO/Secondary Cataract,Lt Eye
 ;;^UTILITY(U,$J,358.3,13041,1,4,0)
 ;;=4^H26.492
 ;;^UTILITY(U,$J,358.3,13041,2)
 ;;=^5005359
 ;;^UTILITY(U,$J,358.3,13042,0)
 ;;=H26.491^^51^627^38
 ;;^UTILITY(U,$J,358.3,13042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13042,1,3,0)
 ;;=3^PCO/Secondary Cataract,Rt Eye
 ;;^UTILITY(U,$J,358.3,13042,1,4,0)
 ;;=4^H26.491
 ;;^UTILITY(U,$J,358.3,13042,2)
 ;;=^5005358
 ;;^UTILITY(U,$J,358.3,13043,0)
 ;;=E11.3292^^51^627^16
 ;;^UTILITY(U,$J,358.3,13043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13043,1,3,0)
 ;;=3^DM2 w/ Mild NPDR w/o Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,13043,1,4,0)
 ;;=4^E11.3292
 ;;^UTILITY(U,$J,358.3,13043,2)
 ;;=^5138336
 ;;^UTILITY(U,$J,358.3,13044,0)
 ;;=E11.3291^^51^627^17
 ;;^UTILITY(U,$J,358.3,13044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13044,1,3,0)
 ;;=3^DM2 w/ Mild NPDR w/o Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,13044,1,4,0)
 ;;=4^E11.3291
 ;;^UTILITY(U,$J,358.3,13044,2)
 ;;=^5138335
 ;;^UTILITY(U,$J,358.3,13045,0)
 ;;=E11.3392^^51^627^18
 ;;^UTILITY(U,$J,358.3,13045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13045,1,3,0)
 ;;=3^DM2 w/ Mod NPDR w/o Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,13045,1,4,0)
 ;;=4^E11.3392
 ;;^UTILITY(U,$J,358.3,13045,2)
 ;;=^5138344
 ;;^UTILITY(U,$J,358.3,13046,0)
 ;;=E11.3391^^51^627^19
 ;;^UTILITY(U,$J,358.3,13046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13046,1,3,0)
 ;;=3^DM2 w/ Mod NPDR w/o Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,13046,1,4,0)
 ;;=4^E11.3391
 ;;^UTILITY(U,$J,358.3,13046,2)
 ;;=^5138343
 ;;^UTILITY(U,$J,358.3,13047,0)
 ;;=E11.9^^51^627^20
 ;;^UTILITY(U,$J,358.3,13047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13047,1,3,0)
 ;;=3^DM2 w/o Complications
 ;;^UTILITY(U,$J,358.3,13047,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,13047,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,13048,0)
 ;;=H02.056^^51^627^46
 ;;^UTILITY(U,$J,358.3,13048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13048,1,3,0)
 ;;=3^Trichiasis w/o Entropion Lt Eye,Unspec Eyelid
 ;;^UTILITY(U,$J,358.3,13048,1,4,0)
 ;;=4^H02.056
 ;;^UTILITY(U,$J,358.3,13048,2)
 ;;=^5004302
 ;;^UTILITY(U,$J,358.3,13049,0)
 ;;=H02.053^^51^627^47
 ;;^UTILITY(U,$J,358.3,13049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13049,1,3,0)
 ;;=3^Trichiasis w/o Entropion Rt Eye,Unspec Eyelid
 ;;^UTILITY(U,$J,358.3,13049,1,4,0)
 ;;=4^H02.053
 ;;^UTILITY(U,$J,358.3,13049,2)
 ;;=^5004300
 ;;^UTILITY(U,$J,358.3,13050,0)
 ;;=H43.813^^51^627^48
 ;;^UTILITY(U,$J,358.3,13050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13050,1,3,0)
 ;;=3^Vitreous Degeneration,Bilateral
 ;;^UTILITY(U,$J,358.3,13050,1,4,0)
 ;;=4^H43.813
 ;;^UTILITY(U,$J,358.3,13050,2)
 ;;=^5005955
 ;;^UTILITY(U,$J,358.3,13051,0)
 ;;=H43.812^^51^627^49
 ;;^UTILITY(U,$J,358.3,13051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13051,1,3,0)
 ;;=3^Vitreous Degeneration,Lt Eye
 ;;^UTILITY(U,$J,358.3,13051,1,4,0)
 ;;=4^H43.812
 ;;^UTILITY(U,$J,358.3,13051,2)
 ;;=^5005954
 ;;^UTILITY(U,$J,358.3,13052,0)
 ;;=H43.811^^51^627^50
